Table 3A. Relationships between GNRI and clinicopathological features in patients with ESCC stage I.
| Characteristics | Total patients | GNRI | ||
|---|---|---|---|---|
| < 97.1 (n = 20) | ≥ 97.1 (n = 53) | p value | ||
| Age (years) | 70 (53–80) | 66 (47–85) | 0.1873 | |
| Sex | 0.9920 | |||
| Male | 62 | 17 | 45 | |
| Female | 11 | 3 | 8 | |
| BMI | 18.1 (13.3 – 20.8) | 22.3 (16.5–31.8) | < 0.0001 | |
| WBC | 5595 (3350–10800) | 5060 (2710–9940) | 0.6922 | |
| Neutrophil | 3383 (1100–9410) | 2920 (860–7296) | 0.4924 | |
| Lymphocyte | 1470 (560–3470) | 1593 (818–2600) | 0.2846 | |
| Platelet | 23.4 (14.2 – 35.6) | 20.7 (11.2 – 30.9) | 0.0987 | |
| Location of tumor | 0.4399 | |||
| Ce | 3 | 1 | 2 | |
| Ut | 1 | 0 | 1 | |
| Mt | 32 | 12 | 20 | |
| Lt | 28 | 5 | 23 | |
| Ae | 9 | 2 | 7 | |
| Tumor size (mm) | 3.9 (0.2–7.0) | 3.7 (0.5–48.0) | 0.4574 | |
| Depth of tumor | 0.8374 | |||
| T1a–1b | 61 | 17 | 44 | |
| 2 | 12 | 3 | 9 | |
| 3 | 0 | 0 | 0 | |
| 4a-4b | 0 | 0 | 0 | |
| Lymph node metastasis | ||||
| N0 | 73 | 20 | 53 | |
| N1 | 0 | 0 | 0 | |
| N2 | 0 | 0 | 0 | |
| N3 | 0 | 0 | 0 | |
| Operation time (min) | 624 (156–891) | 645 (344–1217) | 0.5527 | |
| Intraoperative blood loss (ml) | 415 (50–1840) | 470 (0–3000) | 0.6922 | |
| SCC antigen | 1.1 (0.3–4.2) | 0.6 (0.1–2.3) | 0.0019 | |
| Albumin | 3.7 (3.0–4.6) | 4.2 (3.6–4.9) | < 0.0001 | |
| CRP | 0.20 (0.02–1.82) | 0.20 (0.01–3.26) | 0.9231 | |